Stockreport

Capricor Therapeutics: A High Risk/High Reward Name [Seeking Alpha]

Capricor Therapeutics, Inc.  (CAPR) 
Last capricor therapeutics, inc. earnings: 3/18 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: capricor.com/investors
PDF The company's Deramiocel showed a 54% slowing in upper limb deterioration and a 91% slowing in LVEF decline, supporting a strong case for FDA approval in 2026. CAPR s [Read more]